Screenshot 2022 03 15 21 18 27 90 6012fa4d4ddec268fc5c7112cbb265e7

Özlem türeci

  • Period: to

    She was born in the city of Lastrup in 1967 as a child of an immigrant family from Istanbul.

  • 1995 German Society of Hematology and Oncology - Vincenz Czerny Prize

  • 1997 Calogero Pagliarello Research Award.

  • She continued her work in the company she founded with Uğur Şahin in 2001 and named "Ganymed", inspired by the Turkish word "ganimet".

  • Period: to

    He moved to Mainz in 2001. At the Mainz University Hospital, he conducted studies aiming to fight the immune system against cancer with modified genetic codes.

  • She married her colleague Uğur Şahin, who is also an immigrant from Turkey, in 2002.

  • 2005 German Society of Immunology - Georges Köhler Award

  • Türeci founded BioNTech in 2008 with his wife Uğur Şahin and Austrian immunologist, oncologist Christoph Huber.

  • Ganymed, a pioneer in sensitive antibody therapies for cancer, was sold to Japanese pharmaceutical company Astellas in 2016.

  • She became the company's chief medical officer in 2018.

  • The company, which has 1300 employees as of 2020, initially worked on immunotherapy cancer treatments.

  • With the emergence of the COVID-19 pandemic in 2020, the company turned to finding a coronavirus vaccine.

  • Collaborating with BioNTech on the development of the vaccine, the US pharmaceutical company Pfizer announced on November 9, 2020 that the produced COVID-19 vaccine (BNT162) has achieved success.